Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2024-01-30 00:00:00 ET · period of report 2024-01-29 · accession 0000950170-24-008803 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-01-30 | 2024-01-29 | FATE | Dulac Edward J III | CFO | S - Sale | $5.00 | -1,849 | 103.9K | -2% | -$9,245 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-29 | S | D | 1,849 | $5.00 | 103,926 | D | — | — |